RCKTW — ROCKET PHARMACEUTICALS INC
As of Q2 2026, 1 SEC-registered investment managers reported holding RCKTW (ROCKET PHARMACEUTICALS INC) in their latest 13F filings, with a combined reported value of $1.92K across 310.37K shares. That is -1.1% by share count (-3.61K shares) versus the previous quarter, while reported value moved -70.8%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Q2 2026 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Citadel Advisors history | 310.37K | $1.92K | 0.00% | Hold |
Q1 2026 — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Citadel Advisors history | 310.00K | $6.51K | 0.00% | Hold |
| UBS Group AG history | 3.98K | $84 | 0.00% | New |
Q4 2025 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Citadel Advisors history | 311.49K | $6.17K | 0.00% | Hold |
Q3 2025 — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Citadel Advisors history | 312.79K | $11.26K | 0.00% | Reduce |
| UBS Group AG history | 1.27K | $50 | 0.00% | New |
Q2 2025 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Citadel Advisors history | 314.84K | $9.07K | 0.00% | Reduce |
Q1 2025 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Citadel Advisors history | 317.30K | $14.91K | 0.00% | Reduce |
New Positions (Q2 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
- UBS Group AG sold 3.98K sh · $84
Fund Position History — shares by quarter (top 4 funds)
| Fund | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Citadel Advisors | 310.37K | 310.00K | 311.49K | 312.79K | 314.84K | 317.30K | 337.60K | 343.40K | 370.60K | 364.82K | 300.30K | 324.85K | 352.81K | 357.45K |
| UBS Group AG | — | 3.98K | — | 1.27K | — | — | — | — | 24 | 99 | — | — | — | — |
| JPMorgan Chase & Co | — | — | — | — | — | — | — | — | — | 164.35K | 164.35K | 164.95K | 164.95K | 164.95K |
| Bank of America Corp | — | — | — | — | — | — | — | 100 | — | — | — | 100 | — | — |